These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35922788)

  • 1. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
    Liu Y; Wang T; Li R
    BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
    Wu F; Du Y; Hou X; Cheng W
    BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
    Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
    Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
    Yue K; Yao X
    BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma.
    Qiu L; Tao A; Liu F; Ge X; Li C
    BMC Genom Data; 2022 Nov; 23(1):80. PubMed ID: 36384476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
    Qi L; Tang Z
    Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
    Zhang C; Cai Q; Ke J
    Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma.
    Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L
    Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
    Zhou X; Xue D; Qiu J
    Head Neck; 2022 Jan; 44(1):89-103. PubMed ID: 34713497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
    Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
    Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.